|
|
|
Volumn 45, Issue 1163, 2003, Pages 67-68
|
|
Omalizumab (Xolair): An anti-IgE antibody for asthma
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI-IGE;
ANTIIDIOTYPIC ANTIBODY;
IMMUNOGLOBULIN E;
IMMUNOGLOBULIN E ANTIBODY;
MONOCLONAL ANTIBODY;
OMALIZUMAB;
ADOLESCENT;
ADULT;
ANAPHYLAXIS;
ARTICLE;
ASTHMA;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
FEE;
HAY FEVER;
HUMAN;
IMMUNOLOGY;
RANDOMIZED CONTROLLED TRIAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
ADOLESCENT;
ADULT;
ANAPHYLAXIS;
ANTIBODIES, ANTI-IDIOTYPIC;
ANTIBODIES, MONOCLONAL;
ASTHMA;
DOUBLE-BLIND METHOD;
FEES, PHARMACEUTICAL;
HUMANS;
IMMUNOGLOBULIN E;
INJECTIONS, SUBCUTANEOUS;
RANDOMIZED CONTROLLED TRIALS;
RHINITIS, ALLERGIC, SEASONAL;
|
|
EID: 0141669310
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (10)
|
|
References (0)
|